A Clinical Comparison of 2 Multifocal Toric XR (Extended Range) Contact Lenses
Astigmatism
About this trial
This is an interventional treatment trial for Astigmatism
Eligibility Criteria
Inclusion Criteria:
Subjects will only be eligible for the study if:
- They are aged 40 - 70 years, inclusive.
- They understand their rights as a research subject and are willing and able to sign a Statement of Informed Consent.
- They are willing and able to follow the protocol.
- They have successfully completed the non-dispensing study (C16-597) as the lenses to be worn on this study (C16-599) are predetermined from their participation on study C16-597.
- They have a contact lens spherical prescription between +10.00 to -10.00D (Diopters) (inclusive).
- They have astigmatism between of -0.75 and -5.75DC (based on the calculated ocular refraction) in each eye.
They have an Add component to their spectacle refraction (between +0.75 and
+2.50DS).
- They can be satisfactorily fitted with the study lenses.
- They can attain at least 0.30 logMAR binocular distance high contrast visual acuity with the study lenses within the available power range.
- They have successfully worn soft contact lenses in the last two years.
- They are willing to comply with the wear schedule (at least five days per week and for at least six hours per day).
- They agree not to participate in other clinical research for the duration of this study.
- They own a wearable pair of spectacles.
Exclusion Criteria:
Subjects will not be eligible to take part in the study if:
- They have an ocular disorder which would normally contra-indicate contact lens wear.
- They have a systemic disorder which would normally contra-indicate contact lens wear.
- They are using any topical medication such as eye drops or ointment.
- They have had cataract surgery.
- They have had corneal refractive surgery.
- They have any corneal distortion resulting from previous hard or rigid lens wear or have keratoconus.
- They are pregnant or breast-feeding.
- They have any clinically meaningful slit lamp findings contraindicating contact lens wear (e.g. ≥ Grade 3 finding of oedema, corneal neovascularisation, corneal staining, tarsal abnormalities, conjunctival injection, blepharitis/meibomian gland dysfunction) on the Efron classification scale or any other ocular abnormality that in the opinion of the investigator would contraindicate contact lens wear.
- They have any infectious disease (e.g. hepatitis) which would, in the opinion of the investigator, contraindicate contact lens wear or pose a risk to study personnel; or they have any immunosuppressive disease (e.g. HIV).
- They have a history of anaphylaxis or severe allergic reaction.
- They have taken part in any other contact lens or care solution clinical trial or research, within two weeks prior to starting this study.
Sites / Locations
- Eurolens Research
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
comfilcon A
omafilcon B
Participants were randomized to wear comfilcon A toric lenses for two weeks during the cross over study. The final optical design of comfilcon A contact lens was optimized to improve the quality and two further studies (CV-18-10 and CV-18-11) were conducted after completion of this study to evaluate the modified optical design.
Participants were randomized to wear omafilcon B toric lenses for two weeks during the cross over study.